Inter-Observer Agreement of Whole-Body Computed Tomography in Staging and Response Assessment in Lymphoma: The Lugano Classification
- PMID: 29662570
- PMCID: PMC5894009
- DOI: 10.12659/PJR.902370
Inter-Observer Agreement of Whole-Body Computed Tomography in Staging and Response Assessment in Lymphoma: The Lugano Classification
Abstract
Background: To assess inter-observer agreement of whole-body computed tomography (WBCT) in staging and response assessment in lymphoma according to the Lugano classification.
Material/methods: Retrospective analysis was conducted of 115 consecutive patients with lymphomas (45 females, 70 males; mean age of 46 years). Patients underwent WBCT with a 64 multi-detector CT device for staging and response assessment after a complete course of chemotherapy. Image analysis was performed by 2 reviewers according to the Lugano classification for staging and response assessment.
Results: The overall inter-observer agreement of WBCT in staging of lymphoma was excellent (k=0.90, percent agreement=94.9%). There was an excellent inter-observer agreement for stage I (k=0.93, percent agreement=96.4%), stage II (k=0.90, percent agreement=94.8%), stage III (k=0.89, percent agreement=94.6%) and stage IV (k=0.88, percent agreement=94%). The overall inter-observer agreement in response assessment after a completer course of treatment was excellent (k=0.91, percent agreement=95.8%). There was an excellent inter-observer agreement in progressive disease (k=0.94, percent agreement=97.1%), stable disease (k=0.90, percent agreement=95%), partial response (k=0.96, percent agreement=98.1%) and complete response (k=0.87, Percent agreement=93.3%).
Conclusions: We concluded that WBCT is a reliable and reproducible imaging modality for staging and treatment assessment in lymphoma according to the Lugano classification.
Keywords: Hodgkin Disease; Neoplasm Staging; Response Elements.
Figures





References
-
- Siegel R, Miller KD, Jemal A. Cancer statistics, 2015. Cancer J Clin. 2015;65:5–29. - PubMed
-
- Intlekofer AM, Younes A. Precision therapy for lymphoma – current state and future directions. Nat Rev Clin Oncol. 2014;11:585–96. - PubMed
-
- Ansell SM. Non-Hodgkin lymphoma: Diagnosis and treatment. Mayo Clin Proc. 2015;90:1152–63. - PubMed
-
- Johnson SA, Kumar A, Matasar MJ, et al. Imaging for staging and response assessment in lymphoma. Radiology. 2015;276:323–38. - PubMed
-
- Cheson BD. Staging and response assessment in lymphomas: The new Lugano classification. Clin Oncol. 2015;4:5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources